FDA approves opioid-free pain medication with 'no sign of addiction'
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients. Doctors share what patients should know about the drug.
FDA approves a new pain med that could eliminate addiction. When can GA patients get it?
The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non-addictive alternative.
FDA Approves New Non-Opioid Painkiller, Journavx: 'No Addiction Potential'
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which she says she experienced when taking opioids.
FDA OK's painkiller designed to end opioids' addiction and overdose risk
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' pill,
FDA approves new, non-opioid painkiller Journavx
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.
FDA approves Vertex non-opioid pain drug
The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why it matters: Millions of Americans with acute and chronic pain are prescribed opioids,
FDA Approves First-in-Class Non-Opioid Pain Drug Journavx
The U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine) 50 milligram oral tablets, a groundbreaking non-opioid analgesic designed to treat moderate to severe acute pain
FDA Approves New Non-Opioid Painkiller Journavx for Acute Pain | Watch
The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx (suzetrigine), for adults with moderate to severe acute pain. Developed by Vertex Pharmaceuticals,
Gulf Shores pharmacist sees promise in FDA-approved nonaddictive pain medicine Journavx
For the first time in more than 25 years, the U.S. Food and Drug Administration has signed off on a new type of pain reliever.The newly app
Mesa nonprofits can now apply for funds to combat opioid addiction through $1M grant
To date Mesa received $4.5 million in One Arizona settlement funds. The city will give $1 million to nonprofits working to ...
Fighting addiction means taking a hard look at opioid prescribing
NSDUH only queried opioid misusers about opioid use disorder symptoms. After they changed the protocol and asked all ...
Why single out addiction as more deserving of free medical treatment than other ailments?
What is the argument that makes addiction more deserving of free treatment than heart disease or mental illness? Perhaps all ...
Portland Mayor Wilson announces pilot program for added addiction-recovery beds
Portland Mayor Keith Wilson announced a new pilot program on Monday, as part of the ongoing battle to fight homelessness in ...
Experts: Journavx a prescription to stem Long Island's addiction crisis
Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...
Portland to fund 50 new addiction recovery beds at Bybee Lakes homeless shelter
Portland Mayor Keith Wilson announced today that the city will use about $1.5 million in opioid settlement funds to create the new recovery shelter beds.
WDEL-FM1d
New co-chair of Prescription Opioid Settlement Commission
The Delaware Prescription Opioid Settlement Commission has a new co-chair.
Virginia Attorney General announces $7.4 billion settlement from Oxycontin maker for "fueling" opioid crisis
A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.